Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
INO Transcript
Inovio Pharmaceuticals, Inc. (INO) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Neutral6-4
Inovio Pharmaceuticals, Inc. (INO) Q1 2026 Earnings Call Transcript
Unknown5-13
The earnings call summary indicates a focus on INO-3107, with potential accelerated FDA approval, which is positive. However, the uncertainty surrounding regulatory approval poses a significant risk. The lack of financial details and unclear management responses further contribute to a neutral sentiment. Without market cap details, the stock's reaction is uncertain.
Inovio Pharmaceuticals, Inc. (INO) Q4 2025 Earnings Call Transcript
Unknown3-12
The earnings call presents several challenges: regulatory hurdles, competition from PAPZIMEOS, and cash limitations. Despite some positive feedback on INO-3107, the financials show a shrinking cash position and ongoing net losses. The Q&A reveals uncertainties around FDA timelines and competitive strategies. These factors, combined with the absence of strong financial metrics or guidance, suggest a negative sentiment and potential stock price decline.
Inovio Pharmaceuticals, Inc. (INO) Presents at The Citizens Life Sciences Conference 2026 Transcript
Neutral3-10
INO Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
